Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2009
06/09/2009US7544690 MCH receptor antagonists
06/09/2009US7544689 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors
06/09/2009US7544688 Hetereoaryl nitrile derivatives
06/09/2009US7544687 (2S)-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-ethoxy]-phenyl}-2-(4-m-tolyl-piperazin-1-yl)-propionic acid; hyperglycemia, dyslipidemia, type II diabetes mellitus; (2S)-2-[4-(4-nitro-benzenesulfonyl)-piperazin-1-yl]-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid;
06/09/2009US7544686 Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof
06/09/2009US7544685 2,3-dihydroindole compounds
06/09/2009US7544684 Hydrazono-malonitriles
06/09/2009US7544683 Modulation of H3 receptors; obesity; trans-(4-cyclobutyl-piperazin-1-yl)-[4-(4-[1,2,4]triazol-1-yl-phenoxy)-cyclohexyl]-methanone; cis-[4-(6-chloro-pyridin-3-yloxy)-cyclohexyl]-(4-cyclobutyl-piperazin-1-yl)-methanone,
06/09/2009US7544682 cancer; Methyl 5-((7-(((tert-butylamino)carbonyl)amino)-6-(2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-2-yl)amino)-1,3-benzodioxole-2-carboxylate; treating cellular proliferation disorders
06/09/2009US7544681 with organic acids selected to reduce the side effects induced by the psychotropic drugs and/or to exert anti-proliferative activity
06/09/2009US7544680 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide (CGRP) receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma
06/09/2009US7544679 gamma -secretase inhibitors; to treat Alzheimer's disease, cervical carcinomas and breast carcinomas and malignancies of the hematopoietic system; 2-hydroxy-2-methyl-N-((S)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N'-(2,2,3,3,3-pentafluoro-propyl)-malonamide; good thermodynamic solubility
06/09/2009US7544678 Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
06/09/2009US7544677 Cancer; 2-(methylthio)-6-phenyl-7-(4-{[4-(5-pyridin-2-yl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]methyl}phenyl)pyrido[2,3-d]pyrimidine;serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity
06/09/2009US7544676 Sulfamoyl benzamides and methods of their use
06/09/2009US7544675 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
06/09/2009US7544674 For the treatment of a hyperpigmented skin condition
06/09/2009US7544673 Blends comprising ethylene-vinyl acetate copolymer and poly(alkyl(meth)acrylates or poly(aromatic(meth)acrylates); implantable medical device; permits stents releasing the bioactive agent over time in vivo; provides clear coats, durability, biocompatibility, and release kinetics; drug delivery device
06/09/2009US7544672 Heat Shock Protein 90 (HSP90) inhibiting agents; 3-[2-Amino-4-chloro-7-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-prop-2-yn-1-ol; inflammatory, autoimmune, metabolic disorders, stroke, ischemia, cardiac, neurological disorders, fibrogenetic disorders, cancer
06/09/2009US7544671 Hyaluronan is combined with a polyglycol, such as polyethylene glycol; preparations may maintain their viscosity and lubricity for extended time periods (e.g., 2 years) without requiring refrigeration or special storage conditions
06/09/2009US7544670 HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing
06/09/2009US7544669 Polynucleotide therapy
06/09/2009US7544668 plant extracts triterpene saponins has anti-inflammatory and analgesic activity; solvent extraction and chromatography separation; 3-O- beta -D-glucopyranosyl (1 --> 2)- beta -D-xylopyranosyl-urs-12,18-dien-28-oic acid 28-O- beta -D-glucopyranosyl ester; antiinflammatory agents
06/09/2009US7544667 Hypocholesterolemic compounds
06/09/2009US7544664 Sequences facilitating penetration of a substance of interest
06/09/2009US7544637 2-cyano-3(halo)alkoxy-benzenesulfonamide compounds for combating animal pests
06/09/2009US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders
06/09/2009US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus
06/09/2009US7544497 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease
06/09/2009US7544486 transfecting a mammalian cell with nucleic acid construct to express bone growth factor; implants; inducing osteogenic differentiation, osteoblastic mineralization and/or bone formation in clinical applications; lower doses of each growth factor hence cheaper; for treating bone disorders
06/09/2009US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
06/09/2009US7544373 Minocycline oral dosage forms for the treatment of acne
06/09/2009US7544372 Such as capsules/beads of cyclobenzaprine hydrochloride
06/09/2009US7544370 Mixture with cellulose ethers and water; antiulcer agents
06/09/2009US7544369 pulmonary administration of a liposomal/complexed antiinfective to treat or ameliorate a pulmonary infection in a cystic fibrosis patient; administrated amount is 50% or less of the comparative free drug amount
06/09/2009US7544367 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles
06/09/2009US7544364 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction
06/09/2009US7544363 Exhibit probiotic activity in aerobic conditions; does not contribute to the production of future generation of antibiotic resistant pathogens
06/09/2009US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders
06/09/2009US7544358 Bacterial sepsis, hemorrhagic shock, toxic inhalation, and bleomycin and other drug-induced lung injury; fibronectin and tenascin receptor antagonist; cancer
06/09/2009US7544349 Mixture of dibenzoylmethane compound as sunscreen agents and stabilizer
06/09/2009US7544348 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
06/09/2009US7544301 Citrate-based dialysate chemical formulations
06/09/2009CA2583764C Thrombopoietin activity modulating compounds and methods
06/09/2009CA2519432C Pharmaceutical compositions comprising cetp inhibitors and a water-insoluble concentration-enhancing additive for the treatment of cardiovascular disease
06/09/2009CA2512508C Process for preparing guggulsterones
06/09/2009CA2481005C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
06/09/2009CA2444814C Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
06/09/2009CA2441007C Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
06/09/2009CA2438141C Noninvasive measurements of chemical substances
06/09/2009CA2431125C A method for treating erectile dysfunction
06/09/2009CA2424470C Treatment of gastrointestinal stromal tumors
06/09/2009CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
06/09/2009CA2401812C Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
06/09/2009CA2394232C Dual-release compositions of a cyclooxygenase-2-inhibitor
06/09/2009CA2388939C Therapeutic treatments for blood cell deficiencies
06/09/2009CA2382886C Benzamide formulation with histone deacetylase inhibitor activity
06/09/2009CA2377167C Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
06/09/2009CA2371554C Pharmaceutical composition comprising an angiotensin ii antagonist for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy
06/09/2009CA2355720C New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
06/09/2009CA2352796C Milling process for the production of finely milled medicinal substances
06/09/2009CA2352229C Glyceryl nucleotides, method for the production thereof and their use
06/09/2009CA2350659C Pharmaceutical composition for modified release insulin sensitiser
06/09/2009CA2342861C Method and composition to protect an obligate carnivore from a disease of abnormal carbohydrate metabolism
06/09/2009CA2337772C Skin and tissue care and/or treatment agent
06/09/2009CA2337350C Polyhydroxyalkylpyrazine derivatives, their preparation, and pharmaceutical compositions containing them
06/09/2009CA2326198C Cosolvent formulations
06/09/2009CA2313836C Chitosan and method of preparing chitosan
06/09/2009CA2296727C Pyrazine derivatives, preparation and medicines containing them
06/09/2009CA2276183C Pharmaceutical preparations of glutathione and methods of administration thereof
06/09/2009CA2273354C Oxyiminopregnanecarbolactones
06/09/2009CA2261706C The use of growth factor modulating compounds
06/09/2009CA2251355C Il-6 mutein
06/09/2009CA2251331C Calcilytic compounds
06/09/2009CA2162900C New peptide derivatives
06/04/2009WO2009070799A1 Processes for preparation of crystalline tigecycline form ii
06/04/2009WO2009070788A1 Compositions and methods for enhancing fertility
06/04/2009WO2009070781A1 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
06/04/2009WO2009070779A1 Antibiotic macrocycle compounds and methods of manufacture and use thereof
06/04/2009WO2009070745A1 Graft polymers for enhanced intracellular delivery of antisense molecules
06/04/2009WO2009070744A1 Compositions and methods for inhibiting cytochrome p450 2d6
06/04/2009WO2009070733A1 Peripheral phenolic opioid antagonist
06/04/2009WO2009070687A1 Solvent systems for pour-on formulations for combating parasites
06/04/2009WO2009070684A2 Hemostatic material
06/04/2009WO2009070652A1 Method of treating cancer
06/04/2009WO2009070644A1 Prolyl hydroxylase inhibitors
06/04/2009WO2009070584A1 Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
06/04/2009WO2009070583A1 Pyrido[3,2-e]pyrazines, process for preparing the same, and their use as inhibitors of phosphodiesterase 10
06/04/2009WO2009070567A1 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
06/04/2009WO2009070552A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
06/04/2009WO2009070547A1 Cancer treatment using cox-2 inhibitor and antimetabolite combinations
06/04/2009WO2009070546A1 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
06/04/2009WO2009070533A1 Methods of inhibiting steroyl coa desaturase
06/04/2009WO2009070530A1 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
06/04/2009WO2009070524A1 Pyrrolo[3,2-d]pyrimidine compounds and their use as pi3 kinase and mtor kinase inhibitors
06/04/2009WO2009070516A1 Imidazo-thiazole derivatives as protein kinase inhibitors
06/04/2009WO2009070497A1 SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE
06/04/2009WO2009070485A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES
06/04/2009WO2009070431A1 Antihistamine/corticosteroid preparations for the treatment of atopic dermatitis
06/04/2009WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition
1 ... 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 ... 7860